Trial intelligence / Profile preview

Pilot study of autologous hematopoietic stem cell transplantation in neuromyelitis optica

TCTR20210716002Phase 3Unknown

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Start
Jul 2021
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 3, single-arm trial of autologous hematopoietic stem cells in Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Status: unknown.

02

Drugs

autologous hematopoietic stem cells
03

Conditions

Neuromyelitis Optica Spectrum Disorder (NMOSD)

Beyond the preview

Go deeper on TCTR20210716002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210716002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call